---
category: news
title: "BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501 for the Treatment of Opioid Withdrawal Symptoms"
excerpt: "NEW HAVEN, Conn., Feb. 05, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to identify and advance the next wave of medicines in neuroscience and immuno-oncology,"
publishedDateTime: 2020-02-05T12:00:00Z
webUrl: "https://www.globenewswire.com/news-release/2020/02/05/1980135/0/en/BioXcel-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-BXCL501-for-the-Treatment-of-Opioid-Withdrawal-Symptoms.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: GlobeNewswire
  domain: globenewswire.com

topics:
  - AI
  - AI in Healthcare

secured: "RZfxD1vrOLrMmqxjuOyTelyla/97kg8N0ngilnd+ea7IS3Q17Ue+gv9BCNUdb9VQ7g9PfS0LNYTP0HLe2LFrJRFWp5aAdJzaPzbCxaQVDdqGGo+PTRtjsM9hH7UDjFFVT+IiKOyUownwgWPm69YFX/Ff0JNGAGmZG7Hea1AHW34hTO/+uwLfhFg5jd+YO3e9DfRCYjtLKsT56gsKJMbBm+6OMqFj2ZfU1V/m/DxWrHCF4HUzbrTONlUj71/GAnsqTVHvowoNLH5NZ4NDF+RcLGv7qVOixEu8VCIZoXm8xXW9JBxjq5I5hWHXL6v+93P6;IkTtuPGi53ytRZ1y4c9JAg=="
---

